Showing results (101-110 of 141) with videos related to
Sort By:
Pageof 15
Journal of Crohn'S & Colitis|April 9, 2013
Serum protein profile of Crohn's disease treated with infliximabMaria Gazouli, Athanasios K Anagnostopoulos, Aggeliki Papadopoulou, et al.Journal of Crohn'S & Colitis|September 10, 2015
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's DiseaseThomas Billiet, Konstantinos Papamichael, Magali de Bruyn, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile InfectionNicole C White, Rafael Mendo-Lopez, Konstantinos Papamichael, et al.Journal of Clinical Medicine|November 27, 2024
Morning Salivary Cortisol Has a Positive Correlation with GAD-7 Scores in Patients with Ulcerative ColitisCristina M Castro, Aditya Mithal, Tina Deyhim, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2014
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remissionKonstantinos Papamichael, Niels Vande Casteele, Ann Gils, et al.Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.Inflammatory Bowel Diseases|June 12, 2019
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated CohortDiana M Negoescu, Eva A Enns, Brooke Swanhorst, et al.Journal of Clinical Medicine|December 10, 2021
Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical PatientRodrigo Bremer Nones, Phillip R Fleshner, Natalia Sousa Freitas Queiroz, et al.BMJ Open|April 2, 2022
Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)Konstantinos Papamichael, Vipul Jairath, Guangyong Zou, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 19, 2015
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative ColitisKonstantinos Papamichael, Thomas Van Stappen, Niels Vande Casteele, et al.Pageof 15